Logo image of ALLEX.PA

LEXIBOOK LINGUISTIC ELECTRON (ALLEX.PA) Stock Fundamental Analysis

EPA:ALLEX - Euronext Paris - Matif - FR0000033599 - Common Stock - Currency: EUR

5.22  -0.06 (-1.14%)

Fundamental Rating

7

Taking everything into account, ALLEX scores 7 out of 10 in our fundamental rating. ALLEX was compared to 35 industry peers in the Household Durables industry. ALLEX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ALLEX has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! These ratings could make ALLEX a good candidate for value and growth and quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ALLEX was profitable.
In the past year ALLEX had a positive cash flow from operations.
In the past 5 years ALLEX has always been profitable.
Of the past 5 years ALLEX 4 years had a positive operating cash flow.
ALLEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALLEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M

1.2 Ratios

ALLEX's Return On Assets of 16.65% is amongst the best of the industry. ALLEX outperforms 94.29% of its industry peers.
ALLEX has a better Return On Equity (30.21%) than 91.43% of its industry peers.
ALLEX has a Return On Invested Capital of 25.33%. This is amongst the best in the industry. ALLEX outperforms 91.43% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALLEX is significantly above the industry average of 15.60%.
The 3 year average ROIC (23.84%) for ALLEX is below the current ROIC(25.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 16.65%
ROE 30.21%
ROIC 25.33%
ROA(3y)13.67%
ROA(5y)12.75%
ROE(3y)28.35%
ROE(5y)31.45%
ROIC(3y)23.84%
ROIC(5y)24.08%
ALLEX.PA Yearly ROA, ROE, ROICALLEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

ALLEX's Profit Margin of 9.96% is amongst the best of the industry. ALLEX outperforms 82.86% of its industry peers.
In the last couple of years the Profit Margin of ALLEX has grown nicely.
ALLEX has a Operating Margin of 10.94%. This is in the better half of the industry: ALLEX outperforms 77.14% of its industry peers.
In the last couple of years the Operating Margin of ALLEX has grown nicely.
Looking at the Gross Margin, with a value of 21.26%, ALLEX is doing worse than 80.00% of the companies in the same industry.
ALLEX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.94%
PM (TTM) 9.96%
GM 21.26%
OM growth 3Y4.51%
OM growth 5Y85.85%
PM growth 3Y6.37%
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y3.56%
ALLEX.PA Yearly Profit, Operating, Gross MarginsALLEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

8

2. Health

2.1 Basic Checks

ALLEX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
ALLEX has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ALLEX remains at a similar level compared to 5 years ago.
Compared to 1 year ago, ALLEX has an improved debt to assets ratio.
ALLEX.PA Yearly Shares OutstandingALLEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
ALLEX.PA Yearly Total Debt VS Total AssetsALLEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 4.59 indicates that ALLEX is not in any danger for bankruptcy at the moment.
ALLEX has a better Altman-Z score (4.59) than 85.71% of its industry peers.
ALLEX has a debt to FCF ratio of 1.13. This is a very positive value and a sign of high solvency as it would only need 1.13 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.13, ALLEX belongs to the best of the industry, outperforming 91.43% of the companies in the same industry.
ALLEX has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
ALLEX's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. ALLEX outperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.13
Altman-Z 4.59
ROIC/WACC3.43
WACC7.38%
ALLEX.PA Yearly LT Debt VS Equity VS FCFALLEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M 15M 20M

2.3 Liquidity

ALLEX has a Current Ratio of 2.55. This indicates that ALLEX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.55, ALLEX is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
ALLEX has a Quick Ratio of 1.51. This is a normal value and indicates that ALLEX is financially healthy and should not expect problems in meeting its short term obligations.
ALLEX has a Quick ratio of 1.51. This is in the better half of the industry: ALLEX outperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.55
Quick Ratio 1.51
ALLEX.PA Yearly Current Assets VS Current LiabilitesALLEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.48% over the past year.
ALLEX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 25.32% yearly.
The Revenue has grown by 26.25% in the past year. This is a very strong growth!
The Revenue has been growing by 26.11% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)47.48%
EPS 3Y25.32%
EPS 5YN/A
EPS Q2Q%159.9%
Revenue 1Y (TTM)26.25%
Revenue growth 3Y17.82%
Revenue growth 5Y26.11%
Sales Q2Q%35.61%

3.2 Future

ALLEX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.61% yearly.
Based on estimates for the next years, ALLEX will show a small growth in Revenue. The Revenue will grow by 5.00% on average per year.
EPS Next Y10.53%
EPS Next 2Y11.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.88%
Revenue Next 2Y5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALLEX.PA Yearly Revenue VS EstimatesALLEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALLEX.PA Yearly EPS VS EstimatesALLEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8

9

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.49, the valuation of ALLEX can be described as very cheap.
88.57% of the companies in the same industry are more expensive than ALLEX, based on the Price/Earnings ratio.
ALLEX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.19.
The Price/Forward Earnings ratio is 8.04, which indicates a very decent valuation of ALLEX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALLEX indicates a somewhat cheap valuation: ALLEX is cheaper than 74.29% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.33. ALLEX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 5.49
Fwd PE 8.04
ALLEX.PA Price Earnings VS Forward Price EarningsALLEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

88.57% of the companies in the same industry are more expensive than ALLEX, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALLEX indicates a rather cheap valuation: ALLEX is cheaper than 88.57% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.31
EV/EBITDA 3.6
ALLEX.PA Per share dataALLEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

ALLEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALLEX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.52
PEG (5Y)N/A
EPS Next 2Y11.61%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALLEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LEXIBOOK LINGUISTIC ELECTRON

EPA:ALLEX (7/15/2025, 7:00:00 PM)

5.22

-0.06 (-1.14%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)06-28 2025-06-28/amc
Earnings (Next)08-17 2025-08-17
Inst Owners15.06%
Inst Owner ChangeN/A
Ins Owners47.03%
Ins Owner ChangeN/A
Market Cap40.51M
Analysts86.67
Price Target6.12 (17.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 5.49
Fwd PE 8.04
P/S 0.55
P/FCF 7.31
P/OCF 6.79
P/B 1.66
P/tB 1.7
EV/EBITDA 3.6
EPS(TTM)0.95
EY18.2%
EPS(NY)0.65
Fwd EY12.43%
FCF(TTM)0.71
FCFY13.67%
OCF(TTM)0.77
OCFY14.73%
SpS9.54
BVpS3.14
TBVpS3.08
PEG (NY)0.52
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.65%
ROE 30.21%
ROCE 29.02%
ROIC 25.33%
ROICexc 46.06%
ROICexgc 47.69%
OM 10.94%
PM (TTM) 9.96%
GM 21.26%
FCFM 7.48%
ROA(3y)13.67%
ROA(5y)12.75%
ROE(3y)28.35%
ROE(5y)31.45%
ROIC(3y)23.84%
ROIC(5y)24.08%
ROICexc(3y)37.71%
ROICexc(5y)36.06%
ROICexgc(3y)40.92%
ROICexgc(5y)39.52%
ROCE(3y)27.3%
ROCE(5y)28.24%
ROICexcg growth 3Y10.39%
ROICexcg growth 5Y89.81%
ROICexc growth 3Y10.43%
ROICexc growth 5Y102.3%
OM growth 3Y4.51%
OM growth 5Y85.85%
PM growth 3Y6.37%
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y3.56%
F-Score5
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.13
Debt/EBITDA 0.27
Cap/Depr 35.7%
Cap/Sales 0.58%
Interest Coverage 24.63
Cash Conversion 64.16%
Profit Quality 75.12%
Current Ratio 2.55
Quick Ratio 1.51
Altman-Z 4.59
F-Score5
WACC7.38%
ROIC/WACC3.43
Cap/Depr(3y)102.09%
Cap/Depr(5y)66.24%
Cap/Sales(3y)2.14%
Cap/Sales(5y)1.43%
Profit Quality(3y)89.46%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.48%
EPS 3Y25.32%
EPS 5YN/A
EPS Q2Q%159.9%
EPS Next Y10.53%
EPS Next 2Y11.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.25%
Revenue growth 3Y17.82%
Revenue growth 5Y26.11%
Sales Q2Q%35.61%
Revenue Next Year4.88%
Revenue Next 2Y5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.08%
EBIT growth 3Y23.14%
EBIT growth 5Y134.38%
EBIT Next Year53.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.88%
FCF growth 3YN/A
FCF growth 5Y11.56%
OCF growth 1Y-41.07%
OCF growth 3YN/A
OCF growth 5Y11.83%